E-LIB Suche - Ergebnisse für: Winfree, K.B.

1

PCN131 COST EFFECTIVENESS OF PEMETREXED IN COMBINATION WITH..:

Aggarwal, H. ; Muehlenbein, C.E. ; Klein, T....
Value in Health. 22 (2019) - p. S81 , 2019

Link: https://doi.org/10.1016/..

2

PCN98 A BUDGET IMPACT (BI) ANALYSIS OF PEMETREXED IN COMBIN..:

Aggarwal, H. ; Muehlenbein, C.E. ; Klein, T....
Value in Health. 22 (2019) - p. S74 , 2019

Link: https://doi.org/10.1016/..

3

PCN91 COST-EFFECTIVENESS OF IMMUNOTHERAPY-BASED DRUG REGIME..:

Aggarwal, H. ; Zhang, S. ; Muehlenbein, C.E....
Value in Health. 22 (2019) - p. S453-S454 , 2019

Link: https://doi.org/10.1016/..

4

A Cost-Effectiveness Analysis of First Line Induction and M..:

Kumar, G. ; Woods, B. ; Winfree, K.B....
Value in Health. 17 (2014) 3 - p. A82 , 2014

Link: https://doi.org/10.1016/..

5

A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed ..:

Bryden, P.A. ; Kumar, G. ; Winfree, K.B....
Value in Health. 16 (2013) 7 - p. A410 , 2013

Link: https://doi.org/10.1016/..

6

Identifying the target NSCLC patient for maintenance therap..:

Obasaju, C. ; Bowman, L. ; Wang, P....
Annals of Oncology. 24 (2013) 6 - p. 1534-1542 , 2013

Link: https://doi.org/10.1093/..

7

Evaluation Of Survival Outcomes In Select First-Line Treatm..:

Bhor, M. ; Winfree, K.B. ; Sail, K....
Value in Health. 16 (2013) 3 - p. A1 , 2013

Link: https://doi.org/10.1016/..

8

PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN..:

Le, T.K. ; Winfree, K.B. ; Yang, H....
Value in Health. 14 (2011) 3 - p. A172-A173 , 2011

Link: https://doi.org/10.1016/..

9

CO114 Real-World Experience Among Patients with Mantle Cell..:

Hess, L. ; Khanal, M. ; Sugihara, T....
Value in Health. 26 (2023) 6 - p. S36 , 2023

Link: https://doi.org/10.1016/..

10

PRONOUNCE: Randomized, Open-Label, Phase III Study of First..:

Zinner, Ralph G. ; Obasaju, Coleman K. ; Spigel, David R....
Journal of Thoracic Oncology. 10 (2015) 1 - p. 134-142 , 2015

Link: https://doi.org/10.1097/..

11

Prospective Observational Comparison of Clinical Outcomes B..:

Pennella, Eduardo ; Obasaju, Coleman K. ; Pohl, Gerhardt...
Clinical Lung Cancer. 14 (2013) 6 - p. 726-735 , 2013

Link: https://doi.org/10.1016/..

12

Cost effectiveness of first-line pemetrexed plus platinum c..:

Shah, Manan ; Winfree, Katherine B. ; Peterson, Patrick...
Lung Cancer. 82 (2013) 1 - p. 121-127 , 2013

Link: https://doi.org/10.1016/..

13

CropPol: A dynamic, open and global database on crop pollin..:

Allen‐Perkins, Alfonso ; Magrach, Ainhoa ; Dainese, Matteo...
Ecology. 103 (2022) 3 - p. , 2022

Link: https://doi.org/10.1002/..

14

Skeletal accumulation of fluorescently tagged zoledronate i..:

Swallow, E. A. ; Aref, M. W. ; Chen, N....
Osteoporosis International. 29 (2018) 9 - p. 2139-2146 , 2018

Link: https://doi.org/10.1007/..

15

PRONOUNCE: Randomized, Open-Label, Phase III Study of First..:

Zinner, Ralph G ; Obasaju, Coleman K ; Spigel, David R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2015

Link: http://www.ncbi.nlm.nih...